| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |